Clinical Trials Directory

Trials / Completed

CompletedNCT05572931

Effect of Fu's Subcutaneous Needling on Postoperative Acute Pain in Patients With Lumbar Spine Surgery.

Effect of Fu's Subcutaneous Needling on Postoperative Acute Pain in Patients With Lumbar Spine Surgery: a Single-blinded Randomized, Control Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
49 (actual)
Sponsor
China Medical University Hospital · Academic / Other
Sex
All
Age
20 Years – 85 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to evaluate Fu's Subcutaneous Needling (FSN) in postoperative pain in patients with Lumbar Spine Surgery (LSS). The main questions it aims to answer are: * Is FSN effective for postoperative pain? * Dose FSN decrease the tissue hardness after LSS? * Dose FSN have the effect of anti-inflammatory after LSS? Participants will receive routine analgesic and FSN after LSS. Researchers will compare Sham group to see if FSN being effective for postoperative pain.

Conditions

Interventions

TypeNameDescription
DEVICEFu's Subcutaneous Needling(FSN)Insertion points are both sides of 1) inferior edge of the scapula; 2)the midpoint of inferior edge of the posterior superior iliac spine and the ischial tuberosity. FSN (Trocar Acupuncture Needle, Nanjing FSN Medical Co. , Ltd, China.) ) is a solid needle with plastic cannula tube on the outside. Add on swaying movement (SM) and reperfusion approach (RA) after the needle inserting into the subcutaneous layer. The SM is a horizontal fan sway movement with the base of the needle for the fulcrum, The SM speed is 200 times in 2 minutes. Apply RA when performing SM. RA movement is hip extension in prone position with resistance by physician's hand for 10 seconds. And then rest for 10 seconds. Repeat 3 cycles. The same RA is performed over the other three insertion point.
DEVICEfine acupuncture needle(36G, 0.5 inch, Wujiang city cloud \& dragon medical device Co.,Ltd.) Only inserted to skin, not into the subcutaneous layer. No SM and RA.

Timeline

Start date
2021-03-08
Primary completion
2023-02-01
Completion
2023-06-25
First posted
2022-10-10
Last updated
2024-02-20

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05572931. Inclusion in this directory is not an endorsement.